Analytical Data
-
基因名
HCV-Core
- Application
-
别名
ACY3;ASPA2;N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming)
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8TC12
-
表达区间
22-318aa
-
氨基酸序列
PQIRKMLSSGVCTSTVQLPGKVVVVTGANTGIGKETAKELAQRGARVYLACRDVEKGELVAKEIQTTTGNQQVLVRKLDLSDTKSIRAFAKGFLAEEKHLHVLINNAGVMMCPYSKTADGFEMHIGVNHLGHFLLTHLLLEKLKESAPSRIVNVSSLAHHLGRIHFHNLQGEKFYNAGLAYCHSKLANILFTQELARRLKGSGVTTYSVHPGTVQSELVRHSSFMRWMWWLFSFFIKTPQQGAQTSLHCALTEGLEILSGNHFSDCHVAWVSAQARNETIARRLWDVSCDLLGLPID
-
分子量
49.0kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The HCV-Core recombinant protein has garnered significant attention in the field of hepatitis C virus (HCV) research due to its pivotal role in viral structure and immune response. HCV is a major global health concern, linked to chronic liver disease and hepatocellular carcinoma, affecting millions worldwide. The core protein, encoded by the HCV genome, forms the viral capsid and is crucial for the virus's assembly and release. Understanding the structure and function of the HCV-Core protein is essential for developing effective vaccines and therapeutics. Moreover, this protein is a key target for immune recognition, and it induces epitope-specific T-cell responses, which could be harnessed for immunotherapy. Research efforts have focused on the recombinant production of HCV-Core protein to create diagnostic tools and study its interactions with host immune components. Investigating the conformational properties of the HCV-Core protein enhances our knowledge of HCV pathogenesis and facilitates the identification of potential targets for drug development. With the continued evolution of therapeutic strategies, the characterization of HCV-Core and its role in inducing protective immunity remains a critical area of study, paving the way for innovative approaches to combat HCV infection and improve patient outcomes.
